Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB00730_nanopub.RAXe6v-pS4wVdDB4g9Y4C7BXNiBluqEFClkATzWJ62ovE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB00730 label "DDI between Tacrine and Thiabendazole - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Thiabendazole. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Thiabendazole is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00382_DB00730]" assertion.
- drugbank_resource:DB00382_DB00730 identifier "drugbank_resource:DB00382_DB00730" assertion.
- drugbank_resource:DB00382_DB00730 title "DDI between Tacrine and Thiabendazole - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Thiabendazole. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Thiabendazole is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00730 assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00730 assertion.